Dina Polyak. B. Pharm., Ph.D. Email and Phone Number
Pharmacologist skilled in Cancer Research, Animal Models, Drug Development, Biotechnology and Cell Culture.
-
Principal Scientist - In Vivo Translational ImmunologyArsenalbio Sep 2023 - PresentSouth San Francisco , Ca, Us -
Senior Scientist Ii - In Vivo Translational ImmunologyArsenalbio Mar 2022 - Sep 2023South San Francisco , Ca, Us -
Senior Scientist I - In Vivo Translational ImmunologyArsenalbio Dec 2020 - Mar 2022South San Francisco , Ca, Us -
Postdoctoral Research FellowStanford University School Of Medicine Jan 2017 - Nov 2020Palo Alto, Ca, UsInvestigate mechanism of non-small cell lung cancer (NSCLC) survival and progression in brain and cerebrospinal fluidUtilize cells free and single cell RNA sequencing to study tumor-glia cells cross-talk in the brainMethods:Extraction of live cells from fresh brain tissueIsolation of high-quality RNA from fresh human-derived specimenSingle-cell library preparation and RNAseqDevelop and utilize brain-metastases in-vivo models -
Ph.D. StudentTel Aviv University Oct 2011 - Jan 2018Tel Aviv, IlInvestigated SAR of complex macromolecules for efficient in vitro delivery and activity, evaluated cellular internalization, trafficking, toxicity and activity in murine and human cancer cells.Developed and executed the in vivo pipeline to profile polymer-siRNA complexes in PK, PD, tolerability and efficacy studies. Methods:Cell Culture - Cancer cell growth and purification from tumor tissue; Endothelial cells growth and purification from human umbilical vein.Angiogenesis Assays In Vitro - Migration; Proliferation; Capillary-like tube formation; Invasion; Adhesion and Wound Healing.Ex-vivo Toxicology Assays - Red blood cells lysis; Complement activation; Cytokines secretion. Cell-based assays - Cell proliferation assays; Flow cytometry analysis; In vitro silencing assays using different type of cell lines (cancer and primary). In vivo assays - Injection techniques: Intraperitoneal; Intravenous; Subcutaneous. Antitumor efficacy evaluation of chemotherapeutics/oligonucleotides vs. polymer-drug/oligonucleotides conjugates. Toxicology evaluations - Non-invasive imaging using fluorescence and bioluminescence imaging systems. Biodistribution studies. Pharmacokinetic evaluations. -
Associate Lecturer And Teaching AssistantRuppin Academic Center 2010 - 2016Emek Hefer, IlBasic and advanced pharmacology courses at leading nursing and medical schools in Israel -
PharmacistHillel Yaffe Medical Center Jul 2007 - Oct 2008
Dina Polyak. B. Pharm., Ph.D. Education Details
-
Tel Aviv UniversityOligonucleotides Delivery And Polymer Therapeutics -
Tel Aviv UniversityApplication Of Nanomedicine In Cancer Therapeutics -
Ben-Gurion University Of The NegevPharmacist
Frequently Asked Questions about Dina Polyak. B. Pharm., Ph.D.
What company does Dina Polyak. B. Pharm., Ph.D. work for?
Dina Polyak. B. Pharm., Ph.D. works for Arsenalbio
What is Dina Polyak. B. Pharm., Ph.D.'s role at the current company?
Dina Polyak. B. Pharm., Ph.D.'s current role is Principal Scientist - In Vivo Translational Immunology at ArsenalBio.
What schools did Dina Polyak. B. Pharm., Ph.D. attend?
Dina Polyak. B. Pharm., Ph.D. attended Tel Aviv University, Tel Aviv University, Ben-Gurion University Of The Negev.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial